126 related articles for article (PubMed ID: 1520522)
1. Carbohydrate changes in squamous cell carcinomas.
Dabelsteen E; Clausen H; Mandel U
APMIS Suppl; 1992; 27():130-8. PubMed ID: 1520522
[TBL] [Abstract][Full Text] [Related]
2. Changes in the glycosylation pattern of histo-blood group antigens in benign, premalignant and malignant laryngeal epithelial lesions.
Stenersen TC; Dabelsteen E
APMIS Suppl; 1992; 27():139-48. PubMed ID: 1520523
[TBL] [Abstract][Full Text] [Related]
3. Distribution of histo-blood group antigens in cervical and uterine endometrium.
Stubbe Teglbjaerg C; Ravn V; Mandel U; Dabelsteen E
APMIS Suppl; 1991; 23():100-6. PubMed ID: 1883633
[TBL] [Abstract][Full Text] [Related]
4. Aberrant glycosylation in oral malignant and premalignant lesions.
Dabelsteen E; Clausen H; Mandel U
J Oral Pathol Med; 1991 Sep; 20(8):361-8. PubMed ID: 1941653
[TBL] [Abstract][Full Text] [Related]
5. Cell surface carbohydrates as prognostic markers in human carcinomas.
Dabelsteen E
J Pathol; 1996 Aug; 179(4):358-69. PubMed ID: 8869281
[TBL] [Abstract][Full Text] [Related]
6. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
7. Epithelial isoantigens A, B and H in oral carcinomas.
Gupta YN; Gupta S; Singh IJ; Khanna NN; Agarwal MK
Ear Nose Throat J; 1985 May; 64(5):239-42. PubMed ID: 3996275
[No Abstract] [Full Text] [Related]
8. Premalignant and malignant oral lesions are associated with changes in the glycosylation pattern of carbohydrates related to ABH blood group antigens.
Dabelsteen E; Clausen H; Holmstrup P; Reibel J
APMIS; 1988 Sep; 96(9):813-9. PubMed ID: 3048339
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies.
Mandel U; Hamilton Therkildsen M; Reibel J; Sweeney B; Matsuura H; Hakomori S; Dabelsteen E; Clausen H
APMIS; 1992 Sep; 100(9):817-26. PubMed ID: 1389100
[TBL] [Abstract][Full Text] [Related]
10. Oncofetal fibronectins in oral carcinomas: correlation of two different types.
Mandel U; Gaggero B; Reibel J; Therkildsen MH; Dabelsteen E; Clausen H
APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273
[TBL] [Abstract][Full Text] [Related]
11. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
12. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
[TBL] [Abstract][Full Text] [Related]
13. Fhit protein expression in oral epithelium: immunohistochemical evaluation of three antisera.
van Heerden WF; Swart TJ; van Heerden MB; Pekarsky Y; Sutherland R; Huebner K
Anticancer Res; 2001; 21(4A):2419-23. PubMed ID: 11724301
[TBL] [Abstract][Full Text] [Related]
14. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors.
Skovlund VR
APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838
[TBL] [Abstract][Full Text] [Related]
15. Carbohydrate changes in bladder carcinomas.
Orntoft TF
APMIS Suppl; 1992; 27():181-7. PubMed ID: 1520527
[TBL] [Abstract][Full Text] [Related]
16. Expression of the CA1 determinant by carcinomas and by non-malignant epithelial cells in oral lesions.
Shabana AH; Ivanyi L; Kramer IR
Br J Cancer; 1983 Oct; 48(4):527-31. PubMed ID: 6354238
[TBL] [Abstract][Full Text] [Related]
17. Is the carbohydrate sialosyl-Tn a marker for altered, non-malignant activity in squamous epithelium in the head and neck region?
Bryne M; Gravdahl C; Koppang HS; Kjaerheim A; Dabelsteen E
J Pathol; 1995 Feb; 175(2):237-42. PubMed ID: 7738720
[TBL] [Abstract][Full Text] [Related]
18. Integrin expression in normal, hyperplastic, dysplastic, and malignant oral epithelium.
Jones J; Sugiyama M; Watt FM; Speight PM
J Pathol; 1993 Feb; 169(2):235-43. PubMed ID: 8445489
[TBL] [Abstract][Full Text] [Related]
19. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression.
Bánkfalvi A; Krassort M; Buchwalow IB; Végh A; Felszeghy E; Piffkó J
J Pathol; 2002 Nov; 198(3):343-51. PubMed ID: 12375267
[TBL] [Abstract][Full Text] [Related]
20. Caspase-3 expression is reduced, in the absence of cleavage, in terminally differentiated normal oral epithelium but is increased in oral squamous cell carcinomas and correlates with tumour stage.
Hague A; Eveson JW; MacFarlane M; Huntley S; Janghra N; Thavaraj S
J Pathol; 2004 Oct; 204(2):175-82. PubMed ID: 15376256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
